Table 5.
Data extraction.
Author name and year | Study design | Intervention | Location | Participant | Duration | Measured inflammatory activity | Co-morbidity type | Outcome | Statistical significance |
---|---|---|---|---|---|---|---|---|---|
Alkhalaf et al. (23) | RCTs | Benfotiamine (e) or placebo (c) | Netherlands, 1 outpatient clinic | 86 males: 39 (e) 43 (c); age: 40–75 years Health status: T2DM, UAE | 12 weeks | Hs-CRP, serum amyloid A (sAA), myeloperoxidase (MPO) | Diabetic nephropathy | Intervention insignificant on chronic low-grade inflammation | All p > 0.05 |
Choi et al. (24) | RCTs | Exercise (e) and control (c) groups | Korea, 1 School of Medicine | 80 Females: 38 (e) 37 (c), age: 54.4 ± 6.6 years Health status: T2DM, <2 kg, sedentary lifestyle | 12 weeks | sRAGE, Hs-CRP, IL-6 | Vascular complications, cardiometabolic risk | Decreased hs-CRP, IL-6, waist circumference, systolic and diastolic blood pressure, HbA1c, glucose, AST, apolipoprotein B, and free fatty acid | sRAGE to Hs-CRP (p = 0.019; r = −0.27) |
Homayouni et al. (25) | RCTs | Hesperidin supplement or placebo | Iran, 1 University Medical Clinic | Total: 64; Male: Female: Age: 30–65 years Health status: T2DM, BMI <30 | 6 weeks | TNF-α, IL-6, hs-CRP, total anti-oxidant capacity (TAC) | Vascular complications | Reduced levels of inflammatory markers | IL-6 (p = 0.001) and hs-CRP increased (p < 0.000), TAC (p < 0.000) decreased |
Schell et al. (26) | Randomized crossover study | Dietary raspberries | USA, 1 Clinical Assessment Unit | Total: 25 Male: 5 Female: 20 Age: 54 ± 4.2 years Health status: T2DM, waist circumference (men: >102, women: >89 cm) | 2 days postprandial phase 1 week apart A 1-week washout phase. 10-week “diet supplement phase” of 4 weeks with 2 weeks apart | (IL)-6 and hs-TNF-α | Vascular complications | Red raspberries significantly improved postprandial hyperglycemia and selected markers of inflammation | All p > 0.05 |
Barzilay et al. (27) | RCTs | Salsalate | USA | Total: 227 ≥75 years Male: 130 Female: 97 Health status: T2DM, HBA1c: 7–9.5 | 48 weeks | CRP, TNF-α, WBC types | Vascular complications | Lowered HbA1c, reduction in WBC, neutrophil, and lymphocyte counts indicated anti-inflammatory role. Changes in furosine was positive with CRP and TNF changes but not other glycation products | p > 0.05 for CRP and TNF for furosine changes in salsalate users |
Kadoglou et al. (28) | RCTs | Aerobic training program (exercise) | Greece | Total: 60 Male: 26 Female: 34 Age: 61.64 ± 4.9 years Health status: T2DM, obese, HBA1c: 6.5–8.5, no diabetic angiopathy, postmenopausal women | 6 months (four times/week, 45–60 min/session) | hs-CRP, IL-10, IL-18, TNF-α | Cardiovascular risk, without vascular complications | Exercise training improved metabolic profile and exerts anti-inflammatory effects in T2DM | Reduced CRP (p = 0.04) and IL-18 (p = 0.02). Increased IL-10 (p = 0.039); suppressed IL-18/IL-10 ratio (p = 0.014) |
Krysiak et al. (29) | RCTs | Simvastatin, fenofibrate, simvastatin + fenofibrate, and placebo | Poland, 1 large Teaching Hospital | Total: 190 Age: 25–75 years Male: 108 Female: 82 Health status: untreated T2DM | 180 days−90 days lifestyle modification and 90 days for the intervention | TNF, IL-1, IL-2, IL-6, MCP-1, plasma C reactive protein levels | Systemic inflammation, atherogenic dyslipidemia | Simvastatin and fenofibrate decreased monocyte release of TNF, IL-1, IL-2, IL-6, MCP-1, and lymphocyte release of IL-2, plasma C reactive protein levels. Anti-inflammatory effects of fenofibrate partly correlated with the improvement in insulin sensitivity | All significant (p = 0.001), but weakly correlated for fenofibrate alone on hs-CRP (r = 0.20 to 0.29, p = 0.001) |
Zarezadeh et al. (30) | RCTs | Ginger powder and wheat flour | Iran, 1 large Teaching Hospital | Total: 48 Age: 30–60 years (both genders) Male: Female: Health status: T2DM b/w 1 and 10 years | 10 weeks | Intercellular adhesion molecule 1 (ICAM-1) | Vascular complications, cardiovascular disease | Ginger supplementation decreased sICAM-1 and ADMA after intervention but was marginally significant | Ginger supplement decreased sICAM-1 marginally (p = 0.097) |
Mizoguchi et al. (31) | RCTs | 31 pioglitazone-treated and 21 glimepiride-treated patients. Serial 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) imaging | Japan, 1 large Teaching Hospital | Total: 56 Age: 60–76 years Male: 39 Female: 13 Health Status: T2DM | 4 months | hs-CRP | Impaired glucose tolerance, atherosclerotic plaque inflammation | High-sensitivity C reactive protein was decreased by pioglitazone, whereas it was increased by glimepiride | h-CRP levels decreased by pioglitazone (P < 0.01) but increased marginally by glimepiride(p < 0.05) |